Irfan Zeb
Cardiovascular Disease · Morgantown, WVNPI 1154681229
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $643 of the $919 with a category attached, or 70.0%. Heartflow, Inc. accounts for 92.9% of it on its own, with 3 other manufacturers making up the rest. That places this record below the midpoint for cardiovascular disease clinicians in WV, where the typical reported total is $2,173.
Across 7 payments — averaging $131.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$854
- Medtronic$28
- Boston Scientific$19
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$18
Across 1 payment — averaging $187,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cleerly, Inc.$188K
What the payments were for
- Travel & lodging$64370%
- Food & beverage$27630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 4 | $854 |
| Medtronic | 1 | $28 |
| Boston Scientific | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$738
How this compares
$919 in reported general payments places this provider in the 35th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $21,445 |
| Metoprolol Succinate | 42 | $693 |
| Carvedilol | 23 | $251 |
| Warfarin Sodium | 15 | $191 |
| Atorvastatin Calcium | 21 | $174 |
| Nitroglycerin | 12 | $124 |
| Potassium Chloride | 13 | $111 |
| Rosuvastatin Calcium | 23 | $97 |
| Amlodipine Besylate | 32 | $92 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Morgantown
- Partho SenguptaMorgantown$131K
- Madhavi KadiyalaMorgantown$29K
- David CampseyMorgantown$21K
- Morgan LyonsMorgantown$7K
- Muchi Ditah ChobufoMorgantown$7K
- Raahat BansalMorgantown$6K
- Walid GharibMorgantown$6K
- David TinglerMorgantown$6K
- Yasmin HamiraniMorgantown$5K
- Ruby HavistinMorgantown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.